US biotech Nimble Therapeutics has announced it is operating as a standalone business after spinning out from Roche, focusing on drug R&D based around peptides.
Research and development in the UK will have a major boost thanks to the Medicines Discovery Catapult today launching 22 partnerships with UK-based contract research organisations (CRO
A new antibody has shown potential as treatment for HIV with a mid-stage trial showing it suppressed the virus for up to four months after patients stopped taking antiretroviral medicines.<
Johnson & Johnson’s Janssen pharma unit has announced new results showing that its Invokana diabetes medicine is the first in nearly 20 years to significantly reduce risk of renal failu
